Ptc Therapeutics (PTCT) FCF Margin Growth (3y) (2015 - 2026)
Powered by 
Analysis
Ptc Therapeutics (PTCT) FCF Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -5,426.00 |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 9,545.00 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 4,612.00 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | -3,088.00 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 14,060.00 |
| 10 | Ptc Therapeutics | 5.76 Bn | 3.53 Bn | 340.60 Mn | 4,473.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,473.00 |
| Mar 31, 2026 | -406.00 |
| Dec 31, 2025 | 8,203.00 |
| Sep 30, 2025 | -1,309.00 |
| Jun 30, 2025 | 532.00 |
| Mar 31, 2025 | 14,558.00 |
| Dec 31, 2024 | 3,110.00 |
| Sep 30, 2024 | 172.00 |
| Jun 30, 2024 | -79.00 |
| Mar 31, 2024 | 11,884.00 |
| Dec 31, 2023 | 3,146.00 |
| Sep 30, 2023 | -3,034.00 |
| Jun 30, 2023 | 9,278.00 |
| Mar 31, 2023 | 11,026.00 |
| Dec 31, 2022 | -8,603.00 |
| Sep 30, 2022 | 766.00 |
| Jun 30, 2022 | -62.00 |
| Mar 31, 2022 | 1,274.00 |
| Dec 31, 2021 | -2,558.00 |
| Sep 30, 2021 | -4,234.00 |